Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

NCT06078722 is registered in ClinicalTrials.gov with Kazakh Association of Internal Medicine Specialists as lead sponsor.

NCT NCT06078722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
Lead sponsor
Kazakh Association of Internal Medicine Specialists
Phase
Observational
Overall status
Unknown status
Start date
February 8, 2023
Completion date
February 8, 2025
Enrollment
264 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic-associated fatty liver disease (mafld)